The United States Food and Drug Administration recently approved Tonmya TM (cyclobenzaprine hydrochloride sublingual tablets) ...
The FDA cited concerns about human factors in the use of Aquestive Therapeutics’ Anaphylm sublingual film for anaphylaxis and other type 1 allergic reactions in its complete response letter to the ...
InvestorsHub on MSN
Aquestive shares jump despite FDA setback for Anaphylm
Aquestive Therapeutics (NASDAQ:AQST) shares surged 18% on Monday even after the company disclosed that it had received a ...
Aquestive Therapeutics announced it received a Complete Response Letter (CRL) from the FDA regarding its New Drug Application (NDA) for Anaphylm (dibutepinephrine) Sublingual Film, a noninvasive ...
The FDA has requested new human factors and pharmacology studies for Anaphylm sublingual film following deficiencies in original NDA packaging data.
New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results